About the Journal

On this page: Aims & Scope | Impact Factor | Abstracted/indexed in | ISSN and eISSN | Newsfeeds

Aims and scope of journal

The Pharmacogenomics Journal is a print and electronic journal, which is dedicated to the rapid publication of original research on pharmacogenomics and its clinical applications.

Key areas of coverage include:

  • Personalized medicine
  • Effects of genetic variability on drug toxicity and efficacy
  • Identification and functional characterization of polymorphisms relevant to drug action
  • Pharmacodynamic and pharmacokinetic variations and drug efficacy
  • Integration of new developments in the genome project and proteomics into clinical medicine, pharmacology, and therapeutics
  • Clinical applications of genomic science
  • Identification of novel genomic targets for drug development
  • Potential benefits of pharmacogenomics.

Impact factor

2018 Impact Factor 3.503*

Rank:
73/267 Pharmacology & Pharmacy
57/174 Genetics & Heredity

*2018 Journal Citation Reports® Science Edition (Clarivate Analytics, 2019)

Abstracted/indexed in

Crossref
Pubmed
British Lib
Nature Asia
Chemical Abstracts
Chineseacademy
Ebsco
Globalnewsmedia
Infotrieve
Current Contents/Thomson Reuters
Kesli
Ovid
Proquest Live
Elsevier/Excerpta Medica
Swetsnet
Portico
Keystone-gale
University of Toronto

ISSN and eISSN

The international standard serial number (ISSN) for The Pharmacogenomics Journal is 1470-269X, and the electronic international standard serial number (eISSN) is 1473-1150.

Newsfeeds

The Pharmacogenomics Journal now provides its latest table of contents as an RSS web  feed. This allows users with an RSS reader to receive automatic updates whenever new content is added to these pages.

Receive The Pharmacogenomics Journal's current issue table of contents.

Find out more about RSS feeds, how to download an RSS reader and see all the news feeds offered by Springer Nature.